Ep. 171: Pioneer, Generic, Compounded, and Counterfeit Animal Drugs with Stephanie Batliner
About this episode
Stephanie Batliner discusses the FDA approval process for animal drugs and related topics.
In this episode, Stephanie Batliner, VP of Regulatory Affairs and R&D North America for Bimeda, joined us to discuss the FDA approval process for pioneer and generic animal drugs. She also discussed veterinary devices, pharmacy compounding, counterfeit drugs, and more. This episode of Disease Du Jour is brought to you by Bimeda. GUESTS AND LINKS - EPISODE 171 Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com) Guest: Stephanie Batliner, VP of Regulatory Affairs and R&D North America for Bimeda Podcast Website: Disease Du Jour This episode of Disease Du Jour podcast is brought to you by Bimeda . Connect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)
Sponsors
Bimeda
More episodes of Disease Du Jour
- Ep 180: Pigeon Fever with Dr. Erika Machtinger
- Ep 179: Diagnosing and Managing Equine Soft Tissue Injuries with Dr. Kara Brown
- Ep 178: Metabolic Effects of IA Corticosteroids with Dr. Allen Page
- Ep 177: Neonatal Maladjustment Syndrome and Foal Sepsis with Dr. Lauren Bookbinder
- Ep 176: Equine Intestinal Disease Research with Dr. Liara Gonzalez
- Ep 175: Equine Joint Health and Healing with Dr. Charlie Barton
Explore listener stats, chart rankings, contacts and more on the Disease Du Jour podcast page.